Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Pfizer Inc. (PFE) had Free Cash Flow of $7.28B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$16.58B |
|
$3.24B |
|
$4.03B |
|
$12.55B |
|
$12.91B |
|
$3.67B |
|
$-288.00M |
|
$3.38B |
|
$3.38B |
|
$3.25B |
|
$3.25B |
|
$3.25B |
|
$3.25B |
|
$3.67B |
|
$5.25B |
|
5.70B |
|
5.75B |
|
$0.57 |
|
$0.56 |
|
| Balance Sheet Financials | |
$45.01B |
|
$19.05B |
|
$159.54B |
|
$204.54B |
|
$31.73B |
|
$60.00B |
|
$83.52B |
|
$115.24B |
|
$89.30B |
|
$-28.12B |
|
$89.30B |
|
5.70B |
|
| Cash Flow Statement Financials | |
$8.82B |
|
$865.00M |
|
$-9.03B |
|
$1.20B |
|
$1.88B |
|
$681.00M |
|
$883.00M |
|
$-7.35B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.42 |
|
-- |
|
-- |
|
0.40 |
|
0.70 |
|
75.71% |
|
22.14% |
|
22.14% |
|
-- |
|
20.41% |
|
19.55% |
|
|
Free Cash Flow |
$7.28B |
-- |
|
-- |
|
-- |
|
0.08 |
|
0.40 |
|
1.17 |
|
77.02 |
|
3.64% |
|
-11.56% |
|
1.59% |
|
2.18% |
|
$15.67 |
|
$1.27 |
|
$1.53 |
|